NDC 79903-032-01 - EXTRA STRENGTH ACETAMINOPHEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 79903-032
- Requested NDC
- 79903-032-01
- Package NDCs from labels
- 79903-032-01, 79903-032-02, 79903-032-40, 79903-032-10
- Manufacturer
- Wal-Mart Stores Inc
- Effective date
- 2026-01-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| EXTRA STRENGTH ACETAMINOPHEN - Wal-Mart Stores Inc | Wal-Mart Stores Inc | 2026-01-27 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 79903-032-01 | EXTRA STRENGTH ACETAMINOPHEN | 100 in 1 BOTTLE | TABLET | 100 | 9 | |
| 79903-032-02 | EXTRA STRENGTH ACETAMINOPHEN | 2 in 1 CARTON | TABLET | 2 | 9 | |
| 79903-032-10 | EXTRA STRENGTH ACETAMINOPHEN | 100 in 1 BOTTLE | TABLET | 100 | 9 | |
| 79903-032-40 | EXTRA STRENGTH ACETAMINOPHEN | 1 in 1 CARTON | TABLET | 1 | 9 | |
| 79903-032-40 | EXTRA STRENGTH ACETAMINOPHEN | 40 in 1 BOTTLE | TABLET | 40 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 79903-032-02 | EA - Each | 79903-032 | a10a10d5-5af2-4301-8812-8416ef5a93c1 | 1 | 2023-09-05 |
| 79903-032-10 | EA - Each | 79903-032 | efb4f630-797b-4a17-94d1-02abfd986a35 | 1 | 2022-12-07 |
| 79903-032-40 | EA - Each | 79903-032 | 4422bb8e-0e56-4f3a-af3e-a7762b7f0050 | 1 | 2022-12-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SPF30 SUPER SENSITIVE SUNSCREEN | TITANIUM DIOXIDE | ORGANIC & SUSTAINABLE BEAUTY | fef47045-1d3c-4f08-acec-e96abefbc261 | 2024-11-08 | Warnings | 15FIX9V2JP |
| severe cold and flu relief | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | Rite Aid Corporation | 296f20c0-8b5f-4a08-9329-f93c92e63867 | 2024-11-08 | Warnings | 362O9ITL9D |
| foster and thrive daytime severe cold and flu relief | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | Strategic Sourcing Services LLC | 9d147d1e-8ea5-4e0f-8ae8-1da16f119496 | 2024-11-08 | Warnings | 362O9ITL9D |
| DG Health Cold and Flu Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | Dolgencorp Inc | 23dcb627-c867-435f-9d1a-a9f49e58b58f | 2024-11-08 | Warnings | 362O9ITL9D |
| good sense day time cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | L. Perrigo Company | 4ac6b64a-8214-4b03-8aa5-0d3199cf0b72 | 2024-11-08 | Warnings | 362O9ITL9D |
| Extra Strength TYLENOL Cold Plus Flu Multi-Action Day | ACETAMINOPHEN, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE | Kenvue Brands LLC | 7d3266dc-879a-4d28-b8ea-74d238c3020a | 2024-11-07 | Warnings | 362O9ITL9D |
| TYLENOL 8 HR MUSCLE ACHES AND PAIN | ACETAMINOPHEN | Kenvue Brands LLC | 037ec598-cba6-dbb6-e063-6394a90ac42c | 2024-11-07 | Warnings | 362O9ITL9D |
| Tylenol Cold Plus Head Congestion Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Kenvue Brands LLC | ce43e5c2-fe96-4462-882c-d7479318b33d | 2024-11-07 | Warnings | 362O9ITL9D |
| TYLENOL SINUS PLUS HEADACHE DAY | ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE | Kenvue Brands LLC | e608d214-cc46-4a24-ac85-1040e36e7403 | 2024-11-07 | Warnings | 362O9ITL9D |
| TYLENOL Extra Strength | ACETAMINOPHEN | Kenvue Brands LLC | dd87e342-b0cb-4111-9f15-415dbcda4b77 | 2024-11-07 | Warnings | M013 198440 362O9ITL9D |
| Tylenol Extra Strength | ACETAMINOPHEN | Kenvue Brands LLC | 0c5fdda8-5049-46de-e063-6294a90a592b | 2024-11-07 | Warnings | M013 198440 362O9ITL9D |
| Childrens TYLENOL | ACETAMINOPHEN | Kenvue Brands LLC | 46ddbfde-54ab-4373-b832-b9c0620b1e9d | 2024-11-07 | Warnings | M013 362O9ITL9D |
| Childrens TYLENOL COLD PLUS COUGH PLUS SORE THROAT | ACETAMINOPHEN AND DEXTROMETHORPHAN HYDROBROMIDE | Kenvue Brands LLC | e83f7911-22b4-4ffc-8f49-68f6acd2ebf5 | 2024-11-07 | Warnings | 362O9ITL9D |
| Extra Strength TYLENOL Severe Cough Plus Sore Throat Night | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE AND DOXYLAMINE SUCCINATE. | Kenvue Brands LLC | f81d924e-10e9-0e9d-e053-6294a90a2ddf | 2024-11-07 | Warnings | 362O9ITL9D |
| Childrens TYLENOL COLD Plus FLU | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Kenvue Brands LLC | 8b516736-86ac-47cb-a0ec-038d4c3a0020 | 2024-11-07 | Warnings | 362O9ITL9D |
| Tylenol 8HR | ACETAMINOPHEN | Kenvue Brands LLC | 5d7d1300-bcb8-466a-880b-310b360ee132 | 2024-11-07 | Warnings | 362O9ITL9D |
| Tylenol Cold plus Flu plus Cough Night | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, AND PHENYLEPHRINE HYDROCHLORIDE | Kenvue Brands LLC | e85e5eb9-3ecf-4784-999e-111e38e306f5 | 2024-11-07 | Warnings | 362O9ITL9D |
| TYLENOL COLD PLUS FLU SEVERE | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Kenvue Brands LLC | ef8a846d-4b29-4fd8-a683-fada04d0a2b9 | 2024-11-07 | Warnings | 362O9ITL9D |
| Childrens TYLENOL | ACETAMINOPHEN | Kenvue Brands LLC | 333f6231-3778-4c1f-9558-2afddca22c86 | 2024-11-07 | Warnings | M013 362O9ITL9D |
| Childrens TYLENOL COLD Plus FLU | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Kenvue Brands LLC | 9761c807-75a1-4498-a8c6-1f2b1c9ffde6 | 2024-11-07 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.